Literature DB >> 11689574

Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor.

Alain Roussel1, Nabil Miled, Liliane Berti-Dupuis, Mireille Rivière, Silvia Spinelli, Patrick Berna, Véronique Gruber, Robert Verger, Christian Cambillau.   

Abstract

Fat digestion in humans and some mammals such as dogs requires the successive intervention of two lipases: gastric lipase, which is stable and active despite the highly acidic stomach environment, followed by the classical pancreatic lipase secreted into the duodenum. We previously solved the structure of recombinant human gastric lipase (HGL) at 3.0-A resolution in its closed form; this was the first structure to be described within the mammalian acid lipase family. Here we report on the open structure of the recombinant dog gastric lipase (r-DGL) at 2.7-A resolution in complex with the undecyl-butyl (C11Y4) phosphonate inhibitor. HGL and r-DGL show 85.7% amino acid sequence identity, which makes it relevant to compare the forms from two different species. The open r-DGL structure confirms the previous description of the HGL catalytic triad (Ser(153), His(353), and Asp(324)) with the catalytic serine buried and an oxyanion hole (NH groups of Gln(154) and Leu(67)). In r-DGL, the binding of the C11Y4 phosphonate inhibitor induces part of the cap domain, the lid, to roll over the enzyme surface and to expose a catalytic crevice measuring approximately 20 x 20 x 7 A(3). The C11Y4 phosphonate fits into this crevice, and a molecule of beta-octyl glucoside fills up the crevice. The C11Y4 phosphonate inhibitor and the detergent molecule suggest a possible binding mode for the natural substrates, the triglyceride molecules.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689574     DOI: 10.1074/jbc.M109484200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Inhibitors of polyhydroxyalkanoate (PHA) synthases: synthesis, molecular docking, and implications.

Authors:  Wei Zhang; Chao Chen; Ruikai Cao; Leila Maurmann; Ping Li
Journal:  Chembiochem       Date:  2014-11-13       Impact factor: 3.164

Review 2.  Effects of surfactants on lipase structure, activity, and inhibition.

Authors:  Vincent Delorme; Rabeb Dhouib; Stéphane Canaan; Frédéric Fotiadu; Frédéric Carrière; Jean-François Cavalier
Journal:  Pharm Res       Date:  2011-01-14       Impact factor: 4.200

Review 3.  Lipids in the Stomach - Implications for the Evaluation of Food Effects on Oral Drug Absorption.

Authors:  Mirko Koziolek; Frédéric Carrière; Christopher J H Porter
Journal:  Pharm Res       Date:  2018-02-08       Impact factor: 4.200

4.  Structure of the Catalytic Domain of the Class I Polyhydroxybutyrate Synthase from Cupriavidus necator.

Authors:  Elizabeth C Wittenborn; Marco Jost; Yifeng Wei; JoAnne Stubbe; Catherine L Drennan
Journal:  J Biol Chem       Date:  2016-10-14       Impact factor: 5.157

5.  Structural basis for the recruitment and activation of the Legionella phospholipase VipD by the host GTPase Rab5.

Authors:  María Lucas; Andrew H Gaspar; Chiara Pallara; Adriana Lucely Rojas; Juan Fernández-Recio; Matthias P Machner; Aitor Hierro
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

6.  Direct activation of human phospholipase C by its well known inhibitor u73122.

Authors:  Ryan R Klein; David M Bourdon; Chester L Costales; Craig D Wagner; Wendy L White; Jon D Williams; Stephanie N Hicks; John Sondek; Dhiren R Thakker
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

7.  Crystal structure of the human alkaline sphingomyelinase provides insights into substrate recognition.

Authors:  Alexei Gorelik; Fangyu Liu; Katalin Illes; Bhushan Nagar
Journal:  J Biol Chem       Date:  2017-03-14       Impact factor: 5.157

8.  Synthesis and kinetic evaluation of cyclophostin and cyclipostins phosphonate analogs as selective and potent inhibitors of microbial lipases.

Authors:  Vanessa Point; Raj K Malla; Sadia Diomande; Benjamin P Martin; Vincent Delorme; Frederic Carriere; Stephane Canaan; Nigam P Rath; Christopher D Spilling; Jean-François Cavalier
Journal:  J Med Chem       Date:  2012-11-07       Impact factor: 7.446

9.  In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14.

Authors:  Sylvie Fernandez; Stéphanie Chevrier; Nicolas Ritter; Bruno Mahler; Frédéric Demarne; Frédéric Carrière; Vincent Jannin
Journal:  Pharm Res       Date:  2009-05-19       Impact factor: 4.200

10.  Toward the establishment of standardized in vitro tests for lipid-based formulations. 5. Lipolysis of representative formulations by gastric lipase.

Authors:  Jean-Claude Bakala-N'Goma; Hywel D Williams; Philip J Sassene; Karen Kleberg; Marilyn Calderone; Vincent Jannin; Annabel Igonin; Anette Partheil; Delphine Marchaud; Eduardo Jule; Jan Vertommen; Mario Maio; Ross Blundell; Hassan Benameur; Anette Müllertz; Colin W Pouton; Christopher J H Porter; Frédéric Carrière
Journal:  Pharm Res       Date:  2014-10-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.